A Novel Combined Therapeutic Approach to Endometriosis: Exosomes Derived from Human Wharton’s Jelly Mesenchymal Stem Cells and Etanercept

E+E treatment synergistically reduced key cytokines and enzymes in endometriosis. This approach is a promising means of regulating inflammation.

Authors

Institutions

Publication Details

Journal
Current Molecular Medicine
Published
2025-09-22
DOI
https://doi.org/10.2174/0115665240386032250914233540
Primary Topic
Endometriosis Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Novel Combined Therapeutic Approach to Endometriosis: Exosomes Derived from Human Wharton’s Jelly Mesenchymal Stem Cells and Etanercept

Afshin Amari, Dian Dayer, Mehri Ghafourian, Maryam Farzaneh et al.
Current Molecular Medicine
Endometriosis Research and Treatment
article

A Novel Combined Therapeutic Approach to Endometriosis: Exosomes Derived from Human Wharton’s Jelly Mesenchymal Stem Cells and Etanercept

Afshin Amari, Dian Dayer, Mehri Ghafourian, Maryam Farzaneh, Zorvan Jalili, Roya Mahdavi
article en

Abstract

E+E treatment synergistically reduced key cytokines and enzymes in endometriosis. This approach is a promising means of regulating inflammation.

Current Molecular MedicineVol. 25
Ahvaz Jundishapur University of Medical Sciences (IR), Imam Khomeini Hospital (IR)
Openalex Percentile: Top 66%
Endometriosis Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.